In April of 21Huang ponied up $100k which it seems he may have been instrumental in driving the sp to the highest it got since ipo'ing.
Of course, I guess he may have thought it was on the verge of getting some success with it's testing development.
That is what it will take or the marketmakers get a hold of it and play it.
It's a little pricey from the first time I got in, probably because of Huangs bolstering the sp and sales volume.
Probably why the low interest from investors and the low sharevolume.
It is what it is, but I will put up some more of my playdough to see if what we have can be successful.
I expect this company has a lot of doctors involved who don't really know how to build a company but are willing to let success take the reigns.